Home » Topics » BioWorld Science

BioWorld Science
RSS

Alpha-glucosidase inhibitors from Seikagaku Kogyo

June 21, 1996

Positive analysis results for Amphotec

June 21, 1996

AmBisome line extension receives Danish approval

June 21, 1996

FDA approves abbreviated treatment regimen for Vantin

June 21, 1996

Antifungal sordarin derivatives reported by Glaxo Wellcome

June 21, 1996

Collagen Corporation and Biomatrix enter marketing agreement

June 21, 1996

KCB-1 skin ulcer clinical trials completed

June 21, 1996

Positive phase III results for new Solarase formulation

June 21, 1996

5alpha-reductase type 1 inhibitors from Merck & Co.

June 21, 1996

RPR describes RPR-107880 synthesis

June 21, 1996

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...